US FDA hits Intas Pharma with warning letter; notes data integrity lapses at Ahmedabad plant

US FDA hits Intas Pharma with warning letter; notes data integrity lapses at Ahmedabad plant The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits
#FDA #hits #Intas #Pharma #warning #letter #notes #data #integrity #lapses #Ahmedabad #plant

Leave a Reply